6,625 followers
77,158 followers
A study in @BMCMedicine finds that administration of drugs from the Glucagon-like peptide-1 receptor agonists class is associated with a decreased risk of diabetes retinopathy. The authors suggest further research with a longer follow-up time. https://t.co
196 followers
Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies | BMC Medicine | Full Text https://t.co/pZ91zMib4U
12,595 followers
This is encouraging. I just had the “well…GLP1s may enhance the risk for retinopathy” conversation with a patient recently, so it looks like I can put this concern to bed for now…until the FOCUS trial is published. @BevTchangMD